PH receives another 1M doses of Sinovac vaccine | Inquirer News
Close  

PH receives another 1M doses of Sinovac vaccine

By: - Reporter / @KAguilarINQ
/ 09:32 AM July 14, 2021

MANILA, Philippines — Another 1 million doses of CoronaVac, the COVID-19 vaccine developed by Sinovac, were delivered to the Philippines on Wednesday.

ADVERTISEMENT

The fresh batch of vaccines arrived past 8:00 a.m. via a Cebu Pacific flight at the Ninoy Aquino International Airport. It was welcomed by vaccine czar Carlito Galvez Jr.

This brings the total number of CoronaVac delivered to the Philippines to 13 million, one million doses donated by China and 12 million doses procured by the national government, the private sector and local government units.

FEATURED STORIES

All in all, the Philippines has received 21.7 million vaccines. More than 13 million of these were already administered, with 3.5 million persons now fully vaccinated.

Some 1.5 million more doses of CoronaVac are also expected to arrive in the country on Saturday, July 17, said the National Task Force against COVID-19.

The new batch of COVID-19 vaccines arrived after some local government units suspended administering first doses due to depleting stock of jabs.

EDV

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Coronavac, COVID-19, COVID-19 Vaccines, Sinovac
For feedback, complaints, or inquiries, contact us.


© Copyright 1997-2021 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.